Avery Dennison Corp (AVY) earnings date, results and what the price requires
NYSE · SEC CIK 0000008818 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 30, 2026 | $2.46B | $204.1M | $2.67 | Filing |
| Mar 31, 2026 | Apr 28, 2026 | $2.30B | $168.1M | $2.18 | Filing |
| Dec 31, 2025 | Feb 4, 2026 | $2.27B | $166.4M | $2.16 | Filing |
| Sep 27, 2025 | Oct 22, 2025 | $2.22B | $166.3M | $2.13 | Filing |
| Jun 28, 2025 | Jul 22, 2025 | $2.22B | $189.0M | $2.41 | Filing |
| Mar 29, 2025 | Apr 23, 2025 | $2.15B | $166.3M | $2.09 | Filing |
| Dec 28, 2024 | Jan 30, 2025 | $2.19B | $174.0M | $2.17 | Filing |
| Sep 28, 2024 | Oct 23, 2024 | $2.18B | $181.7M | $2.25 | Filing |
What would Avery Dennison Corp have to report for its valuation to change?
At $175.88, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 10.5% a year, to $15.03. On that path the next quarter needs diluted EPS near $2.35, against $2.13 in the quarter ended Sep 27, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 10.5% | 10.5% |
| EPS needed in final year | $15.03 | $15.03 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. AVY goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.